 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Board of Directors of Lincoln Pharmaceuticals Ltd at their meeting held on October 27, 2016 have considered and approved, issue and allotment of 36,89,200 Equity Shares to the Warrant holders belonging to Promoter/Promoter Group and Non-Promoter Group on account of exercise of their right of Conversion of Warrants into Equity Shares at an exercise price of Rs. 82/- Per Share.
The Board Meeting commenced at 10:30 A.M. and concluded at 11:15 A.M.
Shares of LINCOLN PHARMACEUTICALS LTD. was last trading in BSE at Rs.232.95 as compared to the previous close of Rs. 233.8. The total number of shares traded during the day was 25436 in over 663 trades.
The stock hit an intraday high of Rs. 240.3 and intraday low of 231.55. The net turnover during the day was Rs. 5979389.